Orpheus Bioscience, Inc. — Form D
Orpheus Bioscience, Inc. of MANASSAS, VA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-25. The offering totals $5.0M, of which $3.2M was reported sold. Industry: Other.
Offering
- Filed: 2019-06-25
- Form: D
- Accession: 0001707212-19-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.2M
- Remaining: $1.8M
- Investors: 38
- Date of first sale: 2019-06-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342680
Issuer
- Name: Orpheus Bioscience, Inc.
- CIK: 0001707212
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 9385 DISCOVERY BLVD. #115, MANASSAS, VA, 20109
- Phone: (212) 692-6758
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| John Abeles | Director | Manassas, VA |
| Cohava Gelber | Director | Manassas, VA |
| Guy Yachin | Director | Aurora, CO |
| Guy Yachin | Executive Officer | Aurora, CO |
Other filings by this issuer (3)
More